Advanced search
Start date

Implementation of a molecular biology platform for functional genomics by CRISPR/cas9 system

Grant number: 22/15071-0
Support Opportunities:Scholarships in Brazil - Post-Doctoral
Effective date (Start): January 01, 2023
Effective date (End): December 31, 2024
Field of knowledge:Biological Sciences - Biochemistry - Molecular Biology
Acordo de Cooperação: GlaxoSmithKline
Principal Investigator:Ana Marisa Chudzinski-Tavassi
Grantee:Cassiano Martin Batista
Host Institution: Instituto Butantan. Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil
Host Company:Secretaria da Saúde (São Paulo - Estado). Instituto Butantan
Associated research grant:20/13139-0 - Centre of Excellence in New Target Discovery, AP.PCPE


CENTD has been focusing on the study of new inflammatory targets as well as on the screening for anti-inflammatory compounds from our library of peptides derived from venoms. Our group recently identified potential venom-derived peptides with anti-inflammatory activity in established cell models for screening. In order to identify the molecular targets of these peptides in cell models, a chemoproteomics platform was established in the Laboratory. Thus, the peptides were modified and synthesized with photo-leucine and biotin for an in vivo cross-linked chemoproteomic analysis by UV radiation and additional co-purification using streptavidin columns. Peptide targets have been identified using mass spectrometry. To assess the functional role of each molecular target in the anti-inflammatory context, a validation and gene editing platform was established at CENTD. Thus, the main objective of this project is to carry out the functional study and validation of the molecular targets identified in chemoproteomics through gene editing assays by CRISPR/Cas9. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list using this form.